GROUP EXECUTIVES

Stephen Bradley Saad (52)

Aspen Group Chief Executive

Qualifications: CA(SA)

Appointed: January 1999

Stephen is a founding shareholder of the Aspen Group and his responsibilities extend to include the strategic positioning and global transactions, geographic expansion and product diversification of Aspen in developed and emerging markets as a leading multinational pharmaceutical company.

Gus Attridge (55)

Aspen Deputy Group Chief Executive

Qualifications: CA(SA)

Appointed: January 1999

Gus is a founding shareholder of the Aspen Group and is responsible for the strategic and financial well-being of the Group while also identifying and pursuing appropriate corporate opportunities and global transactions that will further benefit the Group and its stakeholders in its pursuance of global pharmaceutical leadership status.

Sean Capazorio (50)

Aspen Group Finance Officer

Qualifications: BComm, CA(SA)

Appointed: January 1999

Sean takes responsibility for the Group’s finance portfolio across Aspen’s 60 businesses and he is also intricately involved in strategic global transactions.

Carlos Fabián Abelleyra Cordero (54)

Aspen CEO Spanish Latin America

Qualifications: BBA

Appointed: July 2013

Carlos manages Aspen’s business units in Spanish Latin America which comprise Argentina, Chile, Colombia, Ecuador, Mexico, Panama, Peru, the Caribbean and Central America, as well as the Nutritional and Pharma manufacturing facilities in the region.

Dennis Dencher (43)

Aspen CEO Commercial Business Europe

Qualifications: BComm

Appointed: October 2015

Dennis joined Aspen in October 2015. He is responsible for the commercial operations in 45 countries in Europe CIS, which encompasses a net sales turnover of approximately EUR 700 million and a team of some 600 employees.

Noel Guliwe (53)

Aspen Pharmacare CEO - South Africa

Qualifications: BPharm

Appointed: January 2009

Noel joined Aspen in January 2009 and he currently heads up the South African Commercial business.

Lorraine Hill (53)

Aspen Group Operating Officer

Qualifications: BPharm

Appointed: January 1999

Lorraine is responsible for multiple operational areas of the business including regulatory affairs, quality, pharmacovigilence, new product development, manufacturing and supply chain, procurement and third party supply, negotiation and implementation of new business initiatives including global transactions, IT and Group project management.

Samer Kassem (42)

CEO Aspen Global Incorporated

Qualifications: CMA, CFM, CBM, MBA

Appointed: May 2008

Samer joined the Group to set up the global business in Mauritius. He has since assisted in the negotiation, completion and integration of strategic acquisitions as well as establishing commercial operations in countries in Latin America, the Middle East and North Africa in addition to the United States. Samer is also responsible for the Intellectual Property and supply chain of the global brands.

Trevor Ziman (45)

Aspen Asia Pacific CEO

Qualifications: BComm, Dip Acc, CA(SA), CA(Aus)

Appointed: May 2001

Trevor joined the Group as a founder director of Aspen Australia in May 2001 to manage the businesses financial and commercial affairs. He has since assisted in the completion and integration of strategic acquisitions as well as establishing operations in the Philippines, Taiwan, Malaysia, Japan and Hong Kong. In 2014 Trevor was promoted to the position of CEO and more recently he contributed toward establishing Aspen’s operations in China. This region has some 1600 employees.